Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling

被引:80
作者
Ivanov, VN
Krasilnikov, M
Ronai, Z
机构
[1] Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA
[2] Russian Acad Med Sci, Canc Res Ctr, Lab Tumor Biochem, Inst Carcinogenesis, Moscow 115478, Russia
关键词
D O I
10.1074/jbc.M108233200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cooperation between STAT3 and c-Jun results in suppression of Fas Receptor (FasR) transcription, which is often seen in advanced human tumors. To identify requirements for STAT3-Jun cooperation, we elucidated the role of protein kinases that affect both transcription factors. The phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway was found capable of down-regulating both STAT3- and c-Jun-dependent transcription, resulting in derepression of FasR transcription. Conversely, inhibition of PI3K-AKT signaling via the specific pharmacological inhibitor LY294002 up-regulated AP1/Jun- and STAT-dependent transcriptional activities, resulting in suppression of the FasR promoter activities and decreased FasR surface expression. PI3K-AKT's ability to affect FasR transcription was not observed in c-jun null fibroblasts, suggesting that c-Jun is required for PI3K/AKT-mediated regulation of FasR transcription. Interestingly, the dominant negative form of Rac1 (RacN17) was also efficient in relieving FasR expression, suggesting that the increase in FasR expression following AKT stimuli could be mediated via AKT ability to elicit suppression of Rac1, which in turn decreases JNK activities and c-Jun phosphorylation. Overall, our findings demonstrate that through its negative effects on both c-Jun and STAT3, the PI3K-AKT pathway disrupts cooperation between c-Jun and STAT3, which is required for silencing the FasR promoter, resulting in increased expression of surface FasR and concomitant sensitization to FasL-mediated programmed cell death.
引用
收藏
页码:4932 / 4944
页数:13
相关论文
共 100 条
[91]  
VUNIC D, 2000, CURR BIOL, V10, P1359
[92]  
Wan YS, 2001, INT J ONCOL, V18, P461
[93]   PTEN controls tumor-induced angiogenesis [J].
Wen, SH ;
Stolarov, J ;
Myers, MP ;
Su, JD ;
Wigler, MH ;
Tonks, NK ;
Durden, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4622-4627
[94]   MAXIMAL ACTIVATION OF TRANSCRIPTION BY STAT1 AND STAT3 REQUIRES BOTH TYROSINE AND SERINE PHOSPHORYLATION [J].
WEN, ZL ;
ZHONG, Z ;
DARNELL, JE .
CELL, 1995, 82 (02) :241-250
[95]   c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms [J].
Wisdom, R ;
Johnson, RS ;
Moore, C .
EMBO JOURNAL, 1999, 18 (01) :188-197
[96]   Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways [J].
Xiao, GH ;
Jeffers, M ;
Bellacosa, A ;
Mitsuuchi, Y ;
Vande Woude, GF ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :247-252
[97]   RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway [J].
Yamaguchi, Y ;
Katoh, H ;
Yasui, H ;
Mori, K ;
Negishi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (22) :18977-18983
[98]   Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells [J].
Yang, FC ;
Kapur, R ;
King, AJ ;
Tao, W ;
Kim, C ;
Borneo, J ;
Breese, R ;
Marshall, M ;
Dinauer, MC ;
Williams, DA .
IMMUNITY, 2000, 12 (05) :557-568
[99]   Akt regulates cell survival and apoptosis at a postmitochondrial level [J].
Zhou, HL ;
Li, XM ;
Meinkoth, J ;
Pittman, RN .
JOURNAL OF CELL BIOLOGY, 2000, 151 (03) :483-494
[100]   Epigenetic PTEN silencing in malignant melanomas without PTEN mutation [J].
Zhou, XP ;
Gimm, O ;
Hampel, H ;
Niemann, T ;
Walker, MJ ;
Eng, C .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) :1123-1128